Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayo Miyazaki

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diagnostic Cytopathology|August 19, 2009
Comparison of methods trial for high-risk HPVDaniel F I Kurtycz, Michele Smith, Rong He, et al.
Diagnostic Cytopathology|May 15, 2008
Virtual microscopy: an educator's tool for the enhancement of cytotechnology students' locator skillsJimmie Stewart, Kristen Bevans-Wilkins, Abhik Bhattacharya, et al.
Cancer|June 21, 2007
Virtual microscopy for cytology proficiency testing: are we there yet?Jimmie Stewart, Kayo Miyazaki, Kristen Bevans-Wilkins, et al.
Journal of Gastroenterology and Hepatology|March 26, 2003
Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis CYoshiyasu Karino, Jouji Toyota, Masaaki Sugawara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diagnostic Cytopathology|August 19, 2009
Comparison of methods trial for high-risk HPVDaniel F I Kurtycz, Michele Smith, Rong He, et al.
Diagnostic Cytopathology|May 15, 2008
Virtual microscopy: an educator's tool for the enhancement of cytotechnology students' locator skillsJimmie Stewart, Kristen Bevans-Wilkins, Abhik Bhattacharya, et al.
Cancer|June 21, 2007
Virtual microscopy for cytology proficiency testing: are we there yet?Jimmie Stewart, Kayo Miyazaki, Kristen Bevans-Wilkins, et al.
Journal of Gastroenterology and Hepatology|March 26, 2003
Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis CYoshiyasu Karino, Jouji Toyota, Masaaki Sugawara, et al.
Pageof 1